Company intelligence
Metabolon, Inc.
Providing actionable biological insights to answer the toughest questions in life sciences research and drug development
About Metabolon, Inc.
Every biological process leaves a biochemical signature. Genetics, disease, the microbiome, diet, lifestyle and environmental exposures all influence the biochemicals circulating through cells, tissues and biofluids. By measuring these small molecules at scale, metabolomics provides one of the closest views of biological function available. Metabolon is the global leader in metabolomics, delivering high-quality, large-scale biochemical profiling that helps researchers gain deeper insight into biology. From a single biological sample, our technology measures thousands of metabolites, providing a comprehensive snapshot of physiological state and revealing biological changes associated with disease, therapeutic intervention, nutrition and environmental factors. These insights help advance biomarker discovery, drug development, precision medicine and population health. Our scientific leadership is built on the world's largest metabolomics reference library, containing more than 5,400 known compounds, together with industry-leading analytical platforms and 26+ years of metabolomics expertise. This unique combination enables researchers to identify novel biology with confidence and generate reproducible, actionable data. Since our founding in 2000, Metabolon has supported more than 15,000 independent and collaborative studies, contributing to over 4,000 peer-reviewed publications. Headquartered in Research Triangle Park, North Carolina, we partner with pharmaceutical, biotechnology, academic, healthcare and nutrition organizations worldwide to accelerate scientific discovery and improve human health.
Verified activity
Signals from Metabolon, Inc.
5 published signals
Products & Services
Metabolon, Inc. opened commercial orders for Metabolon Verus, with shipping beginning October 1.
Reported by Metabolon, Inc.
Presence & Recognition
Metabolon, Inc. is hosting a Friday Feature on On-Demand Webinars featuring Dr. Dorrain Low.
Reported by Metabolon, Inc.
Research & Knowledge
Metabolon, Inc. highlighted the potential of NAKO to reshape health and disease understanding at population scale through deep, longitudinal phenotyping and metabolomics.
Reported by Greg Michelotti
Presence & Recognition
Metabolon, Inc. is hosting a session by Natasa Giallourou, Associate Director of Scientific Strategy, at the LIPID MAPS Training School 2026 on Thursday, October 15, 2026, focusing on complex lipid profiling and its applications in health, disease, and therapeutic development.
Reported by Metabolon, Inc.
Presence & Recognition
Metabolon, Inc. is heading to UC Davis for MANA 2026 from September 8 to 11 to host the Metabolon Verus Metabolomics Profiling Kit and a lunch presentation.
Reported by Metabolon, Inc.